Interpace Biosciences (IDXG) Market Cap
Market Cap: $8.83M
Avg Volume: 7.93K
Industry: Medical - Diagnostics & Research
Sector: Healthcare
What is Interpace Biosciences's Market Cap?
Interpace Biosciences's current Market Cap as of today is $8.83M.
Interpace Biosciences's quarterly Market Cap as of the most recent quarter is $8.80M.
Interpace Biosciences's annual Market Cap for the fiscal year is $4.68M.
Interpace Biosciences's trailing twelve month (TTM) Market Cap is $8.83M.
Understanding Market Capitalization
Market Capitalization (Market Cap) is the total value of a company's outstanding shares of stock. It is calculated by multiplying the current market price of one share by the total number of outstanding shares.
- It provides a straightforward method of gauging a company’s size.
- Market Cap can be used to compare companies within the same industry.
How is Market Cap calculated?
Market Cap is calculated by multiplying the current share price by the total number of outstanding shares:
In the case of Interpace Biosciences, the market cap is calculated as $2.005 x 4.40M shares = $8.83M.
By understanding a company's Market Cap, investors can gain insights into its size, market position, and potential growth.
Note: The historical market cap chart displays daily market cap values for the past five years.
Note: The market cap vs. enterprise value chart displays quarterly data.
Understanding Market Cap vs. Enterprise Value
Market Capitalization (Market Cap) is the total value of a company's outstanding shares of stock. It represents the market's perception of a company's value and is calculated by multiplying the current stock price by the total number of outstanding shares.
Enterprise Value (EV) is a measure of a company's total value, often considered a more comprehensive alternative to market cap. EV includes not only a company's equity value (market cap) but also its debt and subtracts cash and cash equivalents.
- EV = Market Cap + Total Debt - Cash and Cash Equivalents
While market cap is useful for gauging a company's size, EV is often considered a better metric for assessing a company's true value, especially for potential acquisitions.
End of Year Market Cap
The 2024 value represents the latest market cap, while other years show fiscal year end data.
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $8.83M | 89.42% |
| 2023 | $4.66M | 5.78% |
| 2022 | $4.41M | -85.73% |
| 2021 | $30.89M | 144.16% |
| 2020 | $12.65M | -32.46% |
| 2019 | $18.73M | -16.86% |
| 2018 | $22.53M | 40.46% |
| 2017 | $16.04M | 100.73% |
| 2016 | $7.99M | 11.04% |
| 2015 | $7.20M | -73.02% |
| 2014 | $26.67M | -96.23% |
| 2013 | $707.94M | -36.13% |
| 2012 | $1.11B | 19.57% |
| 2011 | $927.05M | -38.52% |
| 2010 | $1.51B | 120.01% |
| 2009 | $685.36M | 20.02% |
| 2008 | $571.02M | -56.28% |
| 2007 | $1.31B | -7.15% |
| 2006 | $1.41B | -26.79% |
| 2005 | $1.92B | -40.79% |
| 2004 | $3.24B | -14.95% |
| 2003 | $3.82B | 151.95% |
| 2002 | $1.51B | -51.14% |
| 2001 | $3.10B | -78.29% |
| 2000 | $14.28B | 3888.68% |
| 1999 | $358.00M | 18.61% |
| 1998 | $301.83M | 61.61% |
| 1997 | $186.76M | N/A |